TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Tai Chi for Reducing Fibromyalgia Pain
Brief Summary: Data from two recent Tai chi studies have found that Tai Chi yields symptomatic benefit in patients with fibromyalgia (FM). The purpose of this study is to confirm those findings in a larger randomized, controlled clinical trial in a community-based setting. We also sought to extend this line of inquiry by closely examining Tai chi's effect on physical function, specifically postural stability. Towards these ends, we conducted a single-blind, randomized controlled clinical trial of an FM modified 8-form Yang-style Tai chi program compared to standard education. Subjects in both conditions meet in small groups two times weekly for 60 minutes over 12 weeks.


Options:
A: Arm Label: Group education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group education | Arm Label: 8-form Yang-style Tai chi program; Type: EXPERIMENTAL; Interventions: Behavioral: 8-form Yang-style Tai chi | Intervention Type: BEHAVIORAL; Name: 8-form Yang-style Tai chi; Assigned to Arm(s): 8-form Yang-style Tai chi program | Intervention Type: BEHAVIORAL; Name: Group education; Assigned to Arm(s): Group education
B: Intervention Type: BEHAVIORAL; Name: walking program, resistance muscular exercise; Assigned to Arm(s): N/A
C: Arm Label: Strength training; Type: EXPERIMENTAL; Interventions: Behavioral: Strength training | Arm Label: Aerobic exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic exercise | Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): Strength training | Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise
D: Arm Label: CFQ Qigong training group; Type: ACTIVE_COMPARATOR; Interventions: Other: CFQ Qigong | Intervention Type: OTHER; Name: CFQ Qigong; Assigned to Arm(s): CFQ Qigong training group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Tai Chi for Reducing Fibromyalgia Pain
Brief Summary: Data from two recent Tai chi studies have found that Tai Chi yields symptomatic benefit in patients with fibromyalgia (FM). The purpose of this study is to confirm those findings in a larger randomized, controlled clinical trial in a community-based setting. We also sought to extend this line of inquiry by closely examining Tai chi's effect on physical function, specifically postural stability. Towards these ends, we conducted a single-blind, randomized controlled clinical trial of an FM modified 8-form Yang-style Tai chi program compared to standard education. Subjects in both conditions meet in small groups two times weekly for 60 minutes over 12 weeks.


Options:
A: Arm Label: placebo (P); Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: phototherapy (FT); Type: EXPERIMENTAL; Interventions: Radiation: Group Phototherapy | Arm Label: phototherapy+Physical activity (FT+A); Type: EXPERIMENTAL; Interventions: Radiation: Phototherapy + Physical activity | Arm Label: Physical activity (A); Type: EXPERIMENTAL; Interventions: Other: Physical activity | Intervention Type: RADIATION; Name: Group Phototherapy; Assigned to Arm(s): phototherapy (FT) | Intervention Type: RADIATION; Name: Phototherapy + Physical activity; Assigned to Arm(s): phototherapy+Physical activity (FT+A) | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Physical activity (A) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): placebo (P)
B: Arm Label: Dance Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dance | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: Other: Control Group | Intervention Type: BEHAVIORAL; Name: Dance; Assigned to Arm(s): Dance Group | Intervention Type: OTHER; Name: Control Group; Assigned to Arm(s): Control Group
C: Arm Label: Group education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group education | Arm Label: 8-form Yang-style Tai chi program; Type: EXPERIMENTAL; Interventions: Behavioral: 8-form Yang-style Tai chi | Intervention Type: BEHAVIORAL; Name: 8-form Yang-style Tai chi; Assigned to Arm(s): 8-form Yang-style Tai chi program | Intervention Type: BEHAVIORAL; Name: Group education; Assigned to Arm(s): Group education
D: Arm Label: Physcial exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physcial activity | Arm Label: Relaxation exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physcial activity | Intervention Type: BEHAVIORAL; Name: Physcial activity; Assigned to Arm(s): Physcial exercise, Relaxation exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Tai Chi for Reducing Fibromyalgia Pain
Brief Summary: Data from two recent Tai chi studies have found that Tai Chi yields symptomatic benefit in patients with fibromyalgia (FM). The purpose of this study is to confirm those findings in a larger randomized, controlled clinical trial in a community-based setting. We also sought to extend this line of inquiry by closely examining Tai chi's effect on physical function, specifically postural stability. Towards these ends, we conducted a single-blind, randomized controlled clinical trial of an FM modified 8-form Yang-style Tai chi program compared to standard education. Subjects in both conditions meet in small groups two times weekly for 60 minutes over 12 weeks.


Options:
A: Arm Label: Group education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group education | Arm Label: 8-form Yang-style Tai chi program; Type: EXPERIMENTAL; Interventions: Behavioral: 8-form Yang-style Tai chi | Intervention Type: BEHAVIORAL; Name: 8-form Yang-style Tai chi; Assigned to Arm(s): 8-form Yang-style Tai chi program | Intervention Type: BEHAVIORAL; Name: Group education; Assigned to Arm(s): Group education
B: Arm Label: CFQ Qigong training group; Type: ACTIVE_COMPARATOR; Interventions: Other: CFQ Qigong | Intervention Type: OTHER; Name: CFQ Qigong; Assigned to Arm(s): CFQ Qigong training group
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducative program in fibromyalgic patients | Intervention Type: BEHAVIORAL; Name: Psychoeducative program in fibromyalgic patients; Assigned to Arm(s): 1
D: Arm Label: CBT and milnacipran; Type: EXPERIMENTAL; Interventions: Other: CBT and milnacipran | Arm Label: CBT and placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: CBT with a placebo | Arm Label: Educational with milnacipran; Type: ACTIVE_COMPARATOR; Interventions: Drug: Educational with milnacipran | Intervention Type: OTHER; Name: CBT and milnacipran; Assigned to Arm(s): CBT and milnacipran | Intervention Type: BEHAVIORAL; Name: CBT with a placebo; Assigned to Arm(s): CBT and placebo | Intervention Type: DRUG; Name: Educational with milnacipran; Assigned to Arm(s): Educational with milnacipran

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The ME"Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion" (METOCARD-CNIC): A Randomized, Controlled Parallel-group, Observer-blinded Clinical Trial of Early Pre-reperfusion Metoprolol Administration in ST-segment Elevation Myocardial infarctionTOCARD-CNIC Trial.
Brief Summary: The purpose of this study is to test whether early pre-reperfusion metoprolol administration in patients suffering and acute myocardial infarction might reduce the size of myocardial necrosis.


Options:
A: Arm Label: Early metoprolol initiation strategy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Injectable (i.v.) metoprolol tartrate (up to 15 mg). | Arm Label: Delayed metoprolol initiation strategy; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Injectable (i.v.) metoprolol tartrate (up to 15 mg).; Assigned to Arm(s): Early metoprolol initiation strategy
B: Arm Label: Beta-blocker; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carvedilol | Arm Label: Non Beta-blocker; Type: ACTIVE_COMPARATOR; Interventions: Drug: No Carvedilol | Intervention Type: DRUG; Name: Carvedilol; Assigned to Arm(s): Beta-blocker | Intervention Type: DRUG; Name: No Carvedilol; Assigned to Arm(s): Non Beta-blocker
C: Arm Label: 1; Type: N/A; Interventions: Other: Blood sample | Intervention Type: OTHER; Name: Blood sample; Assigned to Arm(s): 1
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Metoprolol controlled release (CR) | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoprolol controlled release (CR); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of the Relationship Between Salivary Phosphorus and Level of Kidney Function
Brief Summary: The specific purpose of this study is to describe the relationship between salivary phosphorus and kidney function, specifically as it relates to serum phosphorus, FGF23, PTH, vitamin D status and urinary excretion of phosphorus.


Options:
A: Arm Label: Placebo 20mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: Placebo 60mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Intervention Type: OTHER; Name: chewing gum; Assigned to Arm(s): K2CG 20mg, K2CG 20mg extender, K2CG 60 mg, K2CG 60 mg extender, Placebo 20mg, Placebo 60mg
B: Arm Label: Renal Function Group #1; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #2; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #3; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #4; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #5; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #6; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #7; Type: N/A; Interventions: N/A
C: Arm Label: Renvela; Type: EXPERIMENTAL; Interventions: Drug: Renvela | Arm Label: Etalpha; Type: EXPERIMENTAL; Interventions: Drug: Etalpha | Intervention Type: DRUG; Name: Renvela; Assigned to Arm(s): Renvela | Intervention Type: DRUG; Name: Etalpha; Assigned to Arm(s): Etalpha
D: Arm Label: PA21 (2.5 g tablet); Type: EXPERIMENTAL; Interventions: Drug: PA21 (2.5 g tablet containing 500 mg iron) | Arm Label: Sevelamer carbonate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sevelamer carbonate | Arm Label: PA21-1 (1.25 g tablet); Type: OTHER; Interventions: Drug: PA21-1 (1.25 g tablet containing 250 mg iron) | Intervention Type: DRUG; Name: PA21 (2.5 g tablet containing 500 mg iron); Assigned to Arm(s): PA21 (2.5 g tablet) | Intervention Type: DRUG; Name: Sevelamer carbonate; Assigned to Arm(s): Sevelamer carbonate | Intervention Type: DRUG; Name: PA21-1 (1.25 g tablet containing 250 mg iron); Assigned to Arm(s): PA21-1 (1.25 g tablet)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of the Relationship Between Salivary Phosphorus and Level of Kidney Function
Brief Summary: The specific purpose of this study is to describe the relationship between salivary phosphorus and kidney function, specifically as it relates to serum phosphorus, FGF23, PTH, vitamin D status and urinary excretion of phosphorus.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Calcium Carbonate (Phosphate Binder); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: 1500 mg/d elemental calcium as calcium carbonate | Intervention Type: DIETARY_SUPPLEMENT; Name: 1500 mg/d elemental calcium as calcium carbonate; Assigned to Arm(s): Calcium Carbonate (Phosphate Binder) | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1 grain (soy) protein diet:; Type: ACTIVE_COMPARATOR; Interventions: Other: grain (soy) protein diet | Arm Label: 2 casein (meat) protein diet; Type: ACTIVE_COMPARATOR; Interventions: Other: casein (meat) protein diet | Intervention Type: OTHER; Name: grain (soy) protein diet; Assigned to Arm(s): 1 grain (soy) protein diet: | Intervention Type: OTHER; Name: casein (meat) protein diet; Assigned to Arm(s): 2 casein (meat) protein diet
C: Arm Label: Renal Function Group #1; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #2; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #3; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #4; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #5; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #6; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #7; Type: N/A; Interventions: N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Niacinamide | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Niacinamide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Two Hypocaloric Diets on Weight Loss and Inflammatory Markers
Brief Summary: The investigators evaluated whether an energy-restricted protein diet with low glycaemic index carbohydrates and soluble fibers (LC-P-LGI) would be more effective than a conventional diet (LC-CONV) on weight-loss and related metabolic variables.


Options:
A: Arm Label: Standard Behavioral Weight Loss Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Behavioral Weight Loss Intervention | Arm Label: Enhanced Weight Loss Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Weight Loss Intervention | Intervention Type: BEHAVIORAL; Name: Standard Behavioral Weight Loss Intervention; Assigned to Arm(s): Standard Behavioral Weight Loss Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Weight Loss Intervention; Assigned to Arm(s): Enhanced Weight Loss Intervention
B: Arm Label: Low glycemic load dietary plan; Type: EXPERIMENTAL; Interventions: Behavioral: Low Glycemic Load Diet versus Low Fat Diet | Arm Label: Low fat diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Glycemic Load Diet versus Low Fat Diet | Intervention Type: BEHAVIORAL; Name: Low Glycemic Load Diet versus Low Fat Diet; Assigned to Arm(s): Low fat diet, Low glycemic load dietary plan
C: Intervention Type: OTHER; Name: LC-P-LGI diet; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: LC-CONV; Assigned to Arm(s): N/A
D: Intervention Type: DIETARY_SUPPLEMENT; Name: Low carbohydrate; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 60-DAY, Open-label, Randomized Study to Evaluate the Efficacy and Safety of Eligen® B12 OR Intramuscularly Administered B12 in Subjects With Low Serum Cobalamin With a 30 Day Extension to 90 Days of Dosing
Brief Summary: The purpose of this study is to compare the efficacy and safety profile of a new oral vitamin B12 formulation (Eligen® B12) with intramuscular B12 in restoring normal B12 (cobalamin) concentrations in subjects with low cobalamin levels (\<350 pg/mL).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: mecobalamin | Intervention Type: DRUG; Name: mecobalamin; Assigned to Arm(s): 1
B: Arm Label: oral Cobalamin (vitamin B12); Type: EXPERIMENTAL; Interventions: Drug: oral Cobalamin (vitamin B12) | Arm Label: intramuscular Cobalamin (vitamin B12); Type: EXPERIMENTAL; Interventions: Drug: intramuscular Cobalamin (vitamin B12) | Intervention Type: DRUG; Name: oral Cobalamin (vitamin B12); Assigned to Arm(s): oral Cobalamin (vitamin B12) | Intervention Type: DRUG; Name: intramuscular Cobalamin (vitamin B12); Assigned to Arm(s): intramuscular Cobalamin (vitamin B12)
C: Arm Label: Oral Eligen® B12; Type: EXPERIMENTAL; Interventions: Other: Vitamin B12 (cyanocobalamin) | Arm Label: IM B12; Type: ACTIVE_COMPARATOR; Interventions: Other: Vitamin B12 (cyanocobalamin) | Intervention Type: OTHER; Name: Vitamin B12 (cyanocobalamin); Assigned to Arm(s): IM B12, Oral Eligen® B12
D: Intervention Type: DRUG; Name: Metformin on top of intensive insulin therapy; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Center for Achieving and Sustaining Improved Health in Harlem: Patient Education to Reduce Postpartum Depressive Symptoms Among Minority Women
Brief Summary: Postpartum depressive symptoms are a major health problem that affects hundreds of women annually. The investgators propose to test an intervention to reduce postpartum depressive symptoms and prevent elevated levels of depressive symptoms in postpartum mothers by preparing and educating women about specific situational triggers of depressive symptoms, by bolstering personal and social resources, by enhancing self-management skills to buffer postpartum demands, and by increasing access to existing healthcare and community resources available to postpartum mothers.


Options:
A: Arm Label: SC + BFI; Type: EXPERIMENTAL; Interventions: Behavioral: WIC support + home-based individual support + Breastfeeding Incentives (SC+BFI) | Arm Label: SC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WIC support + home-based individual support (SC) | Intervention Type: BEHAVIORAL; Name: WIC support + home-based individual support + Breastfeeding Incentives (SC+BFI); Assigned to Arm(s): SC + BFI | Intervention Type: BEHAVIORAL; Name: WIC support + home-based individual support (SC); Assigned to Arm(s): SC
B: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral education; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral education intervention | Intervention Type: BEHAVIORAL; Name: Behavioral education intervention; Assigned to Arm(s): Behavioral education
C: Intervention Type: BEHAVIORAL; Name: Proactive assignment to attend a breastfeeding clinic; Assigned to Arm(s): N/A
D: Arm Label: Obesity Prevention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity Prevention Group | Arm Label: Injury Prevention Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Injury Prevention Group | Intervention Type: BEHAVIORAL; Name: Obesity Prevention Group; Assigned to Arm(s): Obesity Prevention Group | Intervention Type: BEHAVIORAL; Name: Injury Prevention Group; Assigned to Arm(s): Injury Prevention Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Center for Achieving and Sustaining Improved Health in Harlem: Patient Education to Reduce Postpartum Depressive Symptoms Among Minority Women
Brief Summary: Postpartum depressive symptoms are a major health problem that affects hundreds of women annually. The investgators propose to test an intervention to reduce postpartum depressive symptoms and prevent elevated levels of depressive symptoms in postpartum mothers by preparing and educating women about specific situational triggers of depressive symptoms, by bolstering personal and social resources, by enhancing self-management skills to buffer postpartum demands, and by increasing access to existing healthcare and community resources available to postpartum mothers.


Options:
A: Arm Label: Accountable Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Accountable Condition | Arm Label: Control Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Control Condition | Intervention Type: BEHAVIORAL; Name: Accountable Condition; Assigned to Arm(s): Accountable Condition- 8 clinics | Intervention Type: BEHAVIORAL; Name: Control Condition; Assigned to Arm(s): Control Condition- 8 clinics
B: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral education; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral education intervention | Intervention Type: BEHAVIORAL; Name: Behavioral education intervention; Assigned to Arm(s): Behavioral education
C: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Promoting Parental Skills and Enhancing Attachment | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: had home visits by community workers during pregnancy | Intervention Type: BEHAVIORAL; Name: Promoting Parental Skills and Enhancing Attachment; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: had home visits by community workers during pregnancy; Assigned to Arm(s): 1
D: Arm Label: Treatment 2: Transportation, Child Screening/Referral; Type: N/A; Interventions: N/A | Arm Label: Treatment 4: Nurse Home Visiting through Age 2; Type: N/A; Interventions: Behavioral: Nurse Home Visiting | Intervention Type: BEHAVIORAL; Name: Nurse Home Visiting; Assigned to Arm(s): Treatment 4: Nurse Home Visiting through Age 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Center for Achieving and Sustaining Improved Health in Harlem: Patient Education to Reduce Postpartum Depressive Symptoms Among Minority Women
Brief Summary: Postpartum depressive symptoms are a major health problem that affects hundreds of women annually. The investgators propose to test an intervention to reduce postpartum depressive symptoms and prevent elevated levels of depressive symptoms in postpartum mothers by preparing and educating women about specific situational triggers of depressive symptoms, by bolstering personal and social resources, by enhancing self-management skills to buffer postpartum demands, and by increasing access to existing healthcare and community resources available to postpartum mothers.


Options:
A: Intervention Type: BEHAVIORAL; Name: Proactive assignment to attend a breastfeeding clinic; Assigned to Arm(s): N/A
B: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral education; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral education intervention | Intervention Type: BEHAVIORAL; Name: Behavioral education intervention; Assigned to Arm(s): Behavioral education
C: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Improved management of severe neonatal infections; Assigned to Arm(s): N/A

Answer: B